GlassScriptPhysician profile
Jessica Thompson
NPI 1174161491
$7,828.99
in general payments reported to CMS, 2019-2025
19 companies · $1,685 in 2025
The $1,685 reported for 2025 was more than what 90% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,311 · 2022: $1,317 · 2023: $2,145 · 2024: $1,370 · 2025: $1,685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,059 · Education: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,058.76 |
| Education | $141.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,550.77 | 2021-2025 | Invega Sustenna, Invega Trinza |
| Alkermes, INC. | $1,174.85 | 2021-2025 | Aristada, Lybalvi |
| Teva Pharmaceuticals USA, INC. | $1,090.16 | 2022-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Neurocrine Biosciences, INC. | $836.29 | 2021-2025 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $765.31 | 2021-2025 | Caplyta |
| Indivior INC. | $565.39 | 2021-2024 | Perseris |
| Otsuka America Pharmaceutical, INC. | $560.63 | 2021-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| E.R. Squibb & Sons, L.L.C. | $424.08 | 2025 | Cobenfy |
| Abbvie INC. | $274.47 | 2021-2024 | |
| Uswm, LLC | $124.21 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $120.55 | 2023 | Ofev |
| Sunovion Pharmaceuticals INC. | $94.42 | 2021 | |
| Lundbeck LLC | $69.69 | 2021-2024 | Abilify Maintena |
| Vanda Pharmaceuticals INC. | $45.99 | 2025 | Fanapt |
| Axsome Therapeutics, INC. | $39.55 | 2025 | Auvelity |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $26.94 | 2023 | Abilify Maintena |
| Boston Scientific Corporation | $26.04 | 2022 | |
| Medline Industries LP | $21.65 | 2023 | |
| Inogen, INC. | $18.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.